🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zhi Qiao

Tianjin University

ORCID: 0000-0002-2666-2438
MedicineEngineeringComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.

282 citations

Kailei Nong, Per Olav Vandvik, Gordon H Guyatt, Oliver Schnell, Lars Rydén +35 more

7 citations

Zhi Qiao, Lucas M. Glass, Cao Xiao, Fenglong Ma, Junyu Luo

4 citations

Sengjin Choi, Zunwei Chen, Roland Mason Rodriguez, Qiyu Wang, Zhiping Yang +6 more